Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmacopsychiatry ; 56(6): 227-238, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37944561

RESUMO

INTRODUCTION: In patients with a pre-existing mental disorder, an increased risk for a first manifestation of a psychiatric disorder in COVID-19 patients, a more severe course of COVID-19 and an increased mortality have been described. Conversely, observations of lower COVID-19 incidences in psychiatric in-patients suggested protective effects of psychiatric treatment and/or psychotropic drugs against COVID-19. METHODS: A retrospective multi-center study was conducted in 24 German psychiatric university hospitals. Between April and December 2020 (the first and partly second wave of COVID-19), the effects of COVID-19 were assessed on psychiatric in-patient care, the incidence and course of a SARS-CoV-2 infection, and treatment with psychotropic drugs. RESULTS: Patients (n=36,322) were admitted to the hospitals. Mandatory SARS-CoV-2 tests before/during admission were reported by 23 hospitals (95.8%), while 18 (75%) conducted regular testing during the hospital stay. Two hundred thirty-two (0.6%) patients were tested SARS-CoV-2-positive. Thirty-seven (16%) patients were receiving medical treatment for COVID-19 at the psychiatric hospital, ten (4.3%) were transferred to an intermediate/intensive care unit, and three (1.3%) died. The most common prescription for SARS-CoV-2-positive patients was for second-generation antipsychotics (n=79, 28.2%) and antidepressants (SSRIs (n=38, 13.5%), mirtazapine (n=36, 12.9%) and SNRIs (n=29, 10.4%)). DISCUSSION: Contrary to previous studies, our results showed a low number of infections and mortality in SARS-CoV-2-positive psychiatric patients. Several preventive measures seem effective to protect this vulnerable group. Our observations are compatible with the hypothesis of a protective effect of psychotropic drugs against COVID-19 as the overall mortality and need for specific medical treatment was low.


Assuntos
COVID-19 , Humanos , Tratamento Farmacológico da COVID-19 , Prevalência , Psicotrópicos/uso terapêutico , SARS-CoV-2 , Estudos Retrospectivos
2.
Eur Arch Psychiatry Clin Neurosci ; 273(2): 357-365, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35786770

RESUMO

The consequences of the current COVID-19 pandemic for mental health remain unclear, especially regarding the effects on suicidal behaviors. To assess changes in the pattern of suicide attempt (SA) admissions and completed suicides (CS) in association with the COVID-19 pandemic. As part of a longitudinal study, SA admissions and CS are systematically documented and analyzed in all psychiatric hospitals in Frankfurt/Main (765.000 inhabitants). Number, sociodemographic factors, diagnoses and methods of SA and CS were compared between the periods of March-December 2019 and March-December 2020. The number of CS did not change, while the number of SA significantly decreased. Age, sex, occupational status, and psychiatric diagnoses did not change in SA, whereas the percentage of patients living alone while attempting suicide increased. The rate and number of intoxications as a SA method increased and more people attempted suicide in their own home, which was not observed in CS. Such a shift from public places to home is supported by the weekday of SA, as the rate of SA on weekends was significantly lower during the pandemic, likely because of lockdown measures. Only admissions to psychiatric hospitals were recorded, but not to other institutions. As it seems unlikely that the number of SA decreased while the number of CS remained unchanged, it is conceivable that the number of unreported SA cases increased during the pandemic. Our data suggest that a higher number of SA remained unnoticed during the pandemic because of their location and the use of methods associated with lower lethality.


Assuntos
COVID-19 , Tentativa de Suicídio , Humanos , Tentativa de Suicídio/psicologia , Pandemias , Estudos Longitudinais , COVID-19/epidemiologia , Controle de Doenças Transmissíveis
3.
Psychiatr Prax ; 47(7): 376-382, 2020 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-32268416

RESUMO

OBJECTIVE: The Frankfurt Network for Suicide Prevention (FRANS) documents the number of suicides in Frankfurt a. M., in order to determine precise and strategic prevention requirements. METHOD: Analysis of death certificates listing "suicide" as cause of death. Several data points are recorded: Sex, age, method, place and date of suicide, place of residence and place of birth. Further information is drawn from the local register of residents. RESULTS: The results show a relatively consistent number of about 90 suicides per year in Frankfurt a. M., considering the years from 2014 through 2017 the overall suicide rate slightly decreased from 12.84 to 12.68 per 100 000 inhabitants. The highest rates were found amongst the over 81 year-olds. The number of suicides was considerably higher for men than women. The most chosen method was death by hanging. CONCLUSION: These data facilitate more tailored, needs-based prevention measures.


Assuntos
Prevenção do Suicídio , Suicídio , Fatores Etários , Causas de Morte , Feminino , Alemanha , Humanos , Masculino , Fatores Sexuais , Suicídio/estatística & dados numéricos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...